Technology | December 13, 2013

GE Introduces Discovery IGS 740 Mobile Angiography System

Newest addition to IGS series aimed at interventional radiology

GE Introduces Discovery IGS 740 Mobile Angiography System
December 13, 2013 — At RSNA 2013, GE Healthcare introduced the Discovery Interventional Guidance System (IGS) 740, a 510(k)-pending mobile X-ray angiography system with a 41 x 41 cm detector. The system is aimed at interventional radiology market. 
 
The rail-free design aims to allow healthcare professionals ample access to the patient while freeing clinical teams from the constraints of fixed ceiling-mounted system rails. Its wide bore C-Arm and dedicated arm-imaging positions are designed to enable ease in imaging the anatomy of interest, and full patient access from left or right. By eliminating the ceiling rails, installation is intended to be simplified for flexibility in designing the room and positioning ceiling-mounted ancillaries (monitors, rad-shields and lights) where healthcare professionals need them. 
 
“Our goal was to pioneer a solution designed to free interventional radiologists from traditional constraints,” said Chantal Le Chat, general manager of GE Healthcare Premium Angiography. “With the enhanced system mobility of the Discovery IGS 740, clinicians will have full freedom to operate, and we believe this will revolutionize the field of interventional imaging.”
 
GE introduced the first of its IGS series mobile angiography systems at RSNA 2011 and commercialized it in 2012. The IGS series uses a laser guided positioning system to enable it to move anywhere in a room without the need for cables and mounting points. It offers the advantages of high image quality, software and rotational angiography offered by fixed based systems, but the mobility of a mobile C-arm.
 
For more information: www.gehealthcare.com
 

Related Content

Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
#gadolinium Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility
News | Interventional Radiology | April 21, 2020
April 21, 2020 — Guerbet announced that it received U.S.
A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D. 

A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D. 

News | Computed Tomography (CT) | February 10, 2020
February 10, 2020 — The U.S.
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 07, 2020
February 7, 2020 — An ahead-of-print...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Harel Gadot

Harel Gadot, Founder, Executive Chairman and President at XACT Robotics says their system’s small footprint and high mobility design will enable care providers to treat a broad range of patient care needs.

News | Interventional Radiology | November 01, 2019
November 1, 2019 — XACT Robotics Ltd. announced that its firs
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Interventional Radiology | October 28, 2019
October 28, 2019 — Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from im
Exact Imaging Receives FDA 510(k) Clearance for Sterile Transperineal Needle Guide
Technology | Ultrasound Imaging | October 24, 2019
Exact Imaging received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sterile Transperineal Needle...